Drug treatment of COPD

References

• Tashkin DP, Ashutosh K, Bleecker ER, et al. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center study. Am J Med 1986: 81 (Suppl 5A): 81–90
   PubMed Web of Science ®Google Scholar
• Gross NJ, Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease: comparison with a beta-adrenergic agent. Am Rev Respir Dis 1987: 136(5): 1091–4
   PubMed Web of Science ®Google Scholar
• Braun SR, McKenzie WN, Copeland C, et al. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 1989: 149(3): 544–7 [erratum, Arch Intern Med 1990: 150(6): 1242]
   PubMedGoogle Scholar
• Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 1984: 311(7): 421–5
   PubMed Web of Science ®Google Scholar
• Marini JJ, Lakshminarayan S. The effect of atropine inhalation in “irreversible” chronic bronchitis. Chest 1980: 77(5): 591–6
   PubMed Web of Science ®Google Scholar
• Passamonte PM, Martinez AJ. Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels. Chest 1984: 85(5): 610–5
   PubMed Web of Science ®Google Scholar
• Barros MJ, Rees PJ. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Respir Med 1990: 84(5): 371–5
   PubMed Web of Science ®Google Scholar
• Karpel JP, Pesin J, Greenberg D, et al. A comparison of the effects of ipratropium bromide and meta proterenol sulfate in acute exacerbations of COPD. Chest 1990: 98(4): 835–9
   PubMed Web of Science ®Google Scholar
• Karpel PE. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest 1991: 99(4): 871–6
   PubMed Web of Science ®Google Scholar
• Easton PA, Jadue C, Dhingra S, et al. A comparison of the bronchodiladng effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol atone or in sequence. N Engl J Med 1986: 315(12): 735–9
   PubMed Web of Science ®Google Scholar
• LeDoux EJ, Morris JF, Temple WP, et al. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD. Chest 1989: 95(5): 1013–6
   PubMed Web of Science ®Google Scholar
• Higgins RM, Stradling JR, Lane DJ. Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? Chest 1988: 94(4): 718–22
   PubMed Web of Science ®Google Scholar
• Zainudin BM, Biddiscombe M, Tolfree SE, et al. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 1990: 45(6): 469–73
   PubMed Web of Science ®Google Scholar
• MacIntyre NR, Silver RM, Miller CW et al. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985: 13(2): 81–4
   PubMed Web of Science ®Google Scholar
• Crane J, Pearce N, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981–83: case-control study. Lancet 1989: 1 (8644): 917–22
   PubMed Web of Science ®Google Scholar
• Pearce N, Crane J, Burgess C, et al. Fenoterol and asthma mortality. (Letter) Lancet 1989: 1(8648): 1196–7
   PubMed Web of Science ®Google Scholar
• Sly RM Jenne JW, Cohn J. Toxicity of beta-adrenergic drugs. In: Jenne JW Murphy S, eds. Lung biology in health and disease. Vol 31. Drug therapy for asthma: research and clinical practice. New York: Marcel Dekker, 1987: 953–96
   Google Scholar
• Conradson TB, Eklundh G, Olofsson B, et al. Arrhythmogenicity from combined bronchodilator therapy in patients with obstructive lung disease and concomitant ischemic heart disease. Chest 1987: 91(1): 5–9
   PubMed Web of Science ®Google Scholar
• Gelmont DM, Balmes JR, Yee A. Hypokalemia induced by inhaled bronchodilators. Chest 1988: 94(4): 763–6
   PubMed Web of Science ®Google Scholar
• Mestitz H, Copland JM, McDonald CF. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest 1989: 96(6): 1237–40
   PubMed Web of Science ®Google Scholar
• Berenberg MJ, Baigelman W, Cupples LA, et al. Comparison of metered-dose inhaler attached to an aerochamber with an updraft nebulizer for the administration of metaproterenol in hospitalized patients. J Asthma 1985: 22(2): 87–92
   PubMed Web of Science ®Google Scholar
• Turner JR, Corkery KJ, Eckman D, et al. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest 1988: 93(3): 476–81
   PubMed Web of Science ®Google Scholar
• Gunawardena KA, Smith AP, Shankleman J. A comparison of metered dose inhalers with nebulizers from the delivery of ipratropium bromide in domiciliary practice. Br J Dis Chest 1986: 80(2): 170–8
   PubMedGoogle Scholar
• Jenkins SC, Heaton RW, Fulton IJ, et al. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest 1987: 91(6): 804–7
   PubMed Web of Science ®Google Scholar
• Summer W, Elston R, Tharpe L, et al. Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care. Arch Intern Med 1989: 149 (3): 618–23
   PubMedGoogle Scholar
• Jasper AC, Mohsenifar Z, Kahan S, et al. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest 1987: 91(4): 614–8
   PubMed Web of Science ®Google Scholar
• Gay PC, Patel HG, Nelson SB, et al. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991: 99(1): 66–71
   PubMed Web of Science ®Google Scholar
• Fernandez A, Lazaro A, Garcia A, et al. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation: utilization of metered-dose inhalers. Am Rev Respir Dis 1990: 141(1): 164–8
   PubMed Web of Science ®Google Scholar
• Fuller HD, Dolovich MB, Posmituck G, et al. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am Rev Respir Dis 1990: 141(2): 440–4
   PubMed Web of Science ®Google Scholar
• Epstein SW, Manning CP, Ashley MJ, et al. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 1979: 120(7): 813–6
   PubMed Web of Science ®Google Scholar
• De Blaquiere P, Christensen DB, Carter WB, et al. Use and misuse of metered-dose inhalers by patients with chronic lung disease: a controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989: 140(4): 910–6
   PubMed Web of Science ®Google Scholar
• Hess D. The delivery of aerosolized bronchodilator to mechanically ventilated intubated adult patients. (Editorial) Respir Care 1990: 35(5): 399–404
   Google Scholar
• Larsson S, Svedmyr N. Bronchodiladng effect and side effects of beta2-adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof): a study with salbutamol in asthmatics. Am Rev Respir Dis 1977: 116(5): 861–9
   PubMed Web of Science ®Google Scholar
• Rice KL, Leatherman JW, Duane PG, et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease: a controlled trial. Ann Intern Med 1987: 107(3): 305–9
   PubMed Web of Science ®Google Scholar
• Murciano D, Auclair MH, Pariente R, et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med 1989: 320(23): 1521–5
   PubMed Web of Science ®Google Scholar
• Berry RB, Desa MM, Branum JP, et al. Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991: 143(2): 245–50
   PubMed Web of Science ®Google Scholar
• Eiriksson CE Jr, Writer SL, Vestal RE. Theophylline-induced alterations in cardiac electrophysiology in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1987: 135(2): 322–6
   PubMed Web of Science ®Google Scholar
• Bittar G, Friedman HS. The arrhythmogenicity of theophylline: a multivariate analysis of clinical determinants. Chest 1991: 99(6): 1415–20
   PubMed Web of Science ®Google Scholar
• Zwillich CW, Sutton FD, Neff TA, et al. Theophylline-induced seizures in adults: correlation with serum concentrations. Ann Intern Med 1975: 82(6): 784–7
   PubMed Web of Science ®Google Scholar
• Johannesson N, Andersson KE, Joelsson B, et al. Relaxation of lower esophageal sphincter and stimulation of gastric secretion and diuresis by antiasthmatic xanthines: role of adenosine antagonism. Am Rev Respir Dis 1985: 131(1): 26–30
   PubMed Web of Science ®Google Scholar
• Woodcock AA, Johnson MA, Geddes DM. Theophylline prescribing, serum concentrations, and toxicity. Lancet 1983: 2(8350): 610–3
   PubMed Web of Science ®Google Scholar
• Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980: 92(6): 753–8
   PubMed Web of Science ®Google Scholar
• Murata GH, Gorby MS, Chick TW, et al. Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD: effect on patients with a history of multiple relapses. Chest 1990: 98(4): 845–9
   PubMed Web of Science ®Google Scholar
• Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a metaanalysis. Ann Intern Med 1991: 114(3): 216–23
   PubMed Web of Science ®Google Scholar
• Weir DC, Gove RI, Robertson AS, et al. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990: 45(2): 112–7
   PubMed Web of Science ®Google Scholar
• Engel T, Heinig JH, Madsen O, et al. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur Respir J 1989: 2(10): 935–9
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987: 106(2): 196–204
   PubMed Web of Science ®Google Scholar
• Nicotra MB, Rivera M, Awe RJ. Antibiotic therapy of acute exacerbations of chronic bronchitis: a controlled study using tetracycline. Ann Intern Med 1982: 97(1): 18–21
   PubMed Web of Science ®Google Scholar